Ardelyx Inc
ARDXHealthcare|Biotechnology|USA
$5.28
-0.10 (-1.77%)
Tangible Book
$0.60
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (384)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Williams Laura A | Chief Patient Officer | 2026-06-18 | SELL | 81,898 | $5.99 | $490.6K |
| RAAB MICHAEL | President & CEO | 2026-06-15 | SELL | 41,666 | $5.67 | $236.2K |
| Foster Eric Duane | Chief Commercial Officer | 2026-05-21 | SELL | 7,998 | $6.27 | $50.1K |
| Kelliher Mike | Chief Business Officer | 2026-05-21 | SELL | 7,248 | $6.27 | $45.4K |
| Williams Laura A | Chief Patient Officer | 2026-05-21 | SELL | 6,989 | $6.27 | $43.8K |
| Reilly Joseph James | See Remarks | 2026-05-21 | SELL | 3,719 | $6.27 | $23.3K |
| Hohenleitner Susan | CFO | 2026-05-21 | SELL | 1,455 | $6.27 | $9.1K |
| Bishop John E | See Remarks | 2026-05-21 | SELL | 2,306 | $6.27 | $14.5K |
| Brady James Parker | Chief Human Resources Officer | 2026-05-21 | SELL | 1,846 | $6.27 | $11.6K |
| RAAB MICHAEL | President & CEO | 2026-05-21 | SELL | 54,748 | $6.27 | $343.3K |
| RAAB MICHAEL | President & CEO | 2026-05-15 | SELL | 41,666 | $6.28 | $261.7K |
| RAAB MICHAEL | President & CEO | 2026-04-15 | SELL | 41,668 | $6.29 | $262.1K |
| RAAB MICHAEL | President & CEO | 2026-03-16 | SELL | 41,666 | $5.84 | $243.3K |
| MOTT DAVID M | Director | 2026-02-20 | BUY | 333,333 | $5.84 | $1946.7K |
| Bishop John E | See Remarks | 2026-02-20 | SELL | 3,179 | $5.85 | $18.6K |
| Reilly Joseph James | See Remarks | 2026-02-20 | SELL | 4,991 | $5.85 | $29.2K |
| Williams Laura A | See Remarks | 2026-02-20 | SELL | 8,176 | $5.85 | $47.8K |
| Hohenleitner Susan | CFO | 2026-02-20 | SELL | 2,033 | $5.85 | $11.9K |
| Brady James Parker | Chief Human Resources Officer | 2026-02-20 | SELL | 2,543 | $5.85 | $14.9K |
| Kelliher Mike | See Remarks | 2026-02-20 | SELL | 9,595 | $5.85 | $56.1K |
| RAAB MICHAEL | President & CEO | 2026-02-20 | SELL | 45,982 | $5.85 | $269K |
| Foster Eric Duane | Chief Commercial Officer | 2026-02-20 | SELL | 10,439 | $5.85 | $61.1K |
| Williams Laura A | Chief Patient Officer | 2026-01-08 | SELL | 50,000 | $6.98 | $349K |
| Foster Eric Duane | Chief Commercial Officer | 2025-11-21 | SELL | 5,814 | $5.54 | $32.2K |
| Reilly Joseph James | See Remarks | 2025-11-21 | SELL | 11,086 | $5.54 | $61.4K |
| GRAMMER ELIZABETH A | See Remarks | 2025-11-21 | SELL | 5,995 | $5.54 | $33.2K |
| RAAB MICHAEL | President & CEO | 2025-11-21 | SELL | 46,887 | $5.54 | $259.8K |
| Kelliher Mike | See Remarks | 2025-11-21 | SELL | 5,560 | $5.54 | $30.8K |
| Williams Laura A | Chief Patient Officer | 2025-11-21 | SELL | 6,426 | $5.54 | $35.6K |
| Williams Laura A | Chief Patient Officer | 2025-08-26 | SELL | 80,000 | $6.12 | $489.6K |
| Kelliher Mike | Chief Business Officer | 2025-08-21 | SELL | 5,417 | $5.93 | $32.1K |
| Renz Justin A | CFO | 2025-08-21 | SELL | 7,037 | $5.93 | $41.7K |
| RAAB MICHAEL | President & CEO | 2025-08-21 | SELL | 45,687 | $5.93 | $270.9K |
| Foster Eric Duane | Chief Commercial Officer | 2025-08-21 | SELL | 15,308 | $5.93 | $90.8K |
| Williams Laura A | Chief Patient Officer | 2025-08-21 | SELL | 6,261 | $5.93 | $37.1K |
| GRAMMER ELIZABETH A | See Remarks | 2025-08-21 | SELL | 5,841 | $5.93 | $34.6K |
| MOTT DAVID M | Director | 2025-06-16 | BUY | 200,000 | $3.63 | $726K |
| MOTT DAVID M | Director | 2025-06-09 | BUY | 200,000 | $3.69 | $738K |
| Renz Justin A | CFO | 2025-05-20 | SELL | 7,218 | $4.08 | $29.4K |
| RAAB MICHAEL | President & CEO | 2025-05-20 | SELL | 46,817 | $4.08 | $191K |
| Kelliher Mike | See Remarks | 2025-05-20 | SELL | 14,522 | $4.08 | $59.2K |
| GRAMMER ELIZABETH A | See Remarks | 2025-05-20 | SELL | 5,992 | $4.08 | $24.4K |
| Foster Eric Duane | Chief Commercial Officer | 2025-05-20 | SELL | 2,507 | $4.08 | $10.2K |
| Williams Laura A | Chief Medical Officer | 2025-05-20 | SELL | 6,421 | $4.08 | $26.2K |
| MOTT DAVID M | Director | 2025-05-15 | BUY | 100,000 | $3.29 | $329K |
| MOTT DAVID M | Director | 2025-05-02 | BUY | 381,377 | $4.22 | $1609.4K |
| RAAB MICHAEL | President & CEO | 2025-05-02 | SELL | 41,666 | $4.25 | $177.1K |
| RAAB MICHAEL | President & CEO | 2025-04-04 | SELL | 41,666 | $4.59 | $191.2K |
| RAAB MICHAEL | President & CEO | 2025-03-07 | SELL | 41,668 | $5.36 | $223.3K |
| MOTT DAVID M | Director | 2025-02-24 | BUY | 77,729 | $5 | $388.6K |
| Williams Laura A | Chief Medical Officer | 2025-02-20 | SELL | 4,941 | $5.62 | $27.8K |
| Renz Justin A | CFO | 2025-02-20 | SELL | 5,171 | $5.62 | $29.1K |
| RAAB MICHAEL | President & CEO | 2025-02-20 | SELL | 22,964 | $5.62 | $129.1K |
| GRAMMER ELIZABETH A | See Remarks | 2025-02-20 | SELL | 4,291 | $5.62 | $24.1K |
| RAAB MICHAEL | President & CEO | 2025-01-31 | SELL | 41,666 | $5.36 | $223.3K |
| MOTT DAVID M | Director | 2025-01-21 | BUY | 199,000 | $4.99 | $993K |
| RAAB MICHAEL | President & CEO | 2025-01-07 | SELL | 41,666 | $5.31 | $221.2K |
| MOTT DAVID M | Director | 2024-12-19 | BUY | 213,300 | $4.67 | $996.1K |
| RAAB MICHAEL | President & CEO | 2024-12-10 | SELL | 25,000 | $5.26 | $131.5K |
| RAAB MICHAEL | President & CEO | 2024-11-25 | SELL | 25,000 | $5.38 | $134.5K |
| Williams Laura A | Chief Medical Officer | 2024-11-20 | SELL | 7,366 | $4.79 | $35.3K |
| Rosenbaum David P. | Chief Development Officer | 2024-11-20 | SELL | 7,184 | $4.79 | $34.4K |
| Renz Justin A | CFO | 2024-11-20 | SELL | 5,260 | $4.79 | $25.2K |
| RAAB MICHAEL | President & CEO | 2024-11-20 | SELL | 31,980 | $4.79 | $153.2K |
| GRAMMER ELIZABETH A | See Remarks | 2024-11-20 | SELL | 7,046 | $4.79 | $33.8K |
| Blanks Robert | See Remarks | 2024-11-20 | SELL | 4,941 | $4.79 | $23.7K |
| MOTT DAVID M | Director | 2024-11-13 | BUY | 215,868 | $4.62 | $997.3K |
| RAAB MICHAEL | President & CEO | 2024-11-11 | SELL | 2,743 | $4.9 | $13.4K |
| Rosenbaum David P. | Chief Development Officer | 2024-11-06 | SELL | 27,171 | $6.1 | $165.7K |
| Rosenbaum David P. | Chief Development Officer | 2024-11-04 | SELL | 27,172 | $5.95 | $161.7K |
| RAAB MICHAEL | President & CEO | 2024-10-28 | SELL | 25,000 | $5.91 | $147.8K |
| RAAB MICHAEL | President & CEO | 2024-10-11 | SELL | 7,500 | $6.01 | $45.1K |
| Rosenbaum David P. | Chief Development Officer | 2024-09-27 | SELL | 49,564 | $6.92 | $343K |
| RAAB MICHAEL | President & CEO | 2024-09-26 | SELL | 3,000 | $6.07 | $18.2K |
| Rosenbaum David P. | Chief Development Officer | 2024-09-13 | SELL | 5,312 | $6.26 | $33.3K |
| RAAB MICHAEL | President & CEO | 2024-09-11 | SELL | 35,000 | $5.61 | $196.4K |
| RAAB MICHAEL | President & CEO | 2024-08-27 | SELL | 7,500 | $6.22 | $46.7K |
| Rosenbaum David P. | Chief Development Officer | 2024-08-20 | SELL | 40,507 | $5.97 | $241.8K |
| Williams Laura A | Chief Medical Officer | 2024-08-20 | SELL | 7,412 | $5.86 | $43.4K |
| Rosenbaum David P. | Chief Development Officer | 2024-08-20 | SELL | 7,219 | $5.86 | $42.3K |
| Renz Justin A | CFO | 2024-08-20 | SELL | 5,289 | $5.86 | $31K |
| RAAB MICHAEL | President & CEO | 2024-08-20 | SELL | 32,225 | $5.86 | $188.8K |
| GRAMMER ELIZABETH A | See Remarks | 2024-08-20 | SELL | 7,089 | $5.86 | $41.5K |
| Felsch Robert Ora | See Remarks | 2024-08-20 | SELL | 3,567 | $5.86 | $20.9K |
| Blanks Robert | See Remarks | 2024-08-20 | SELL | 4,969 | $5.86 | $29.1K |
| RAAB MICHAEL | President & CEO | 2024-08-12 | SELL | 1,229 | $5.71 | $7K |
| RAAB MICHAEL | President & CEO | 2024-07-29 | SELL | 30,000 | $5.64 | $169.2K |
| RAAB MICHAEL | President & CEO | 2024-07-15 | SELL | 7,500 | $5.97 | $44.8K |
| RAAB MICHAEL | President & CEO | 2024-06-28 | SELL | 2,310 | $6.59 | $15.2K |
| Blanks Robert | See Remarks | 2024-06-21 | SELL | 38,000 | $5.96 | $226.5K |
| RAAB MICHAEL | President & CEO | 2024-06-13 | SELL | 35,000 | $6.65 | $232.8K |
| Williams Laura A | Chief Medical Officer | 2024-06-05 | SELL | 145,000 | $7.12 | $1032.4K |
| Rosenbaum David P. | Chief Development Officer | 2024-06-03 | SELL | 17,872 | $7 | $125.1K |
| RAAB MICHAEL | President & CEO | 2024-05-29 | SELL | 7,500 | $6.72 | $50.4K |
| Rodriguez Susan | Chief Commercial Officer | 2024-05-21 | SELL | 6,703 | $7.81 | $52.4K |
| Renz Justin A | CFO | 2024-05-21 | SELL | 5,167 | $7.81 | $40.4K |
| RAAB MICHAEL | President & CEO | 2024-05-21 | SELL | 31,484 | $7.81 | $245.9K |
| GRAMMER ELIZABETH A | See Remarks | 2024-05-21 | SELL | 6,927 | $7.81 | $54.1K |
| Felsch Robert Ora | See Remarks | 2024-05-21 | SELL | 3,485 | $7.81 | $27.2K |
| Blanks Robert | See Remarks | 2024-05-21 | SELL | 4,855 | $7.81 | $37.9K |
| Williams Laura A | Chief Medical Officer | 2024-05-21 | SELL | 4,794 | $7.81 | $37.4K |
| Rosenbaum David P. | Chief Development Officer | 2024-05-21 | SELL | 7,053 | $7.81 | $55.1K |
| RAAB MICHAEL | President & CEO | 2024-05-14 | SELL | 3,000 | $7.99 | $24K |
| Felsch Robert Ora | See Remarks | 2024-05-06 | SELL | 207,988 | $8.81 | $1832.4K |
| GRAMMER ELIZABETH A | See Remarks | 2024-05-06 | SELL | 284,170 | $8.88 | $2523.4K |
| GRAMMER ELIZABETH A | See Remarks | 2024-05-03 | SELL | 45,000 | $9 | $405K |
| Williams Laura A | Chief Medical Officer | 2024-05-03 | SELL | 39,949 | $8.35 | $333.6K |
| RAAB MICHAEL | President & CEO | 2024-04-29 | SELL | 30,000 | $6.4 | $192K |
| RAAB MICHAEL | President & CEO | 2024-04-15 | SELL | 7,500 | $7.06 | $53K |
| RAAB MICHAEL | President & CEO | 2024-04-01 | SELL | 1,518 | $7.31 | $11.1K |
| GRAMMER ELIZABETH A | See Remarks | 2024-03-20 | SELL | 86,000 | $7.73 | $664.8K |
| Rosenbaum David P. | Chief Development Officer | 2024-02-26 | SELL | 5,183 | $9.2 | $47.7K |
| Rosenbaum David P. | Chief Development Officer | 2024-02-20 | SELL | 7,311 | $8.75 | $64K |
| Renz Justin A | CFO | 2024-02-20 | SELL | 5,341 | $8.75 | $46.7K |
| RAAB MICHAEL | President & CEO | 2024-02-20 | SELL | 22,917 | $8.75 | $200.5K |
| Blanks Robert | See Remarks | 2024-02-20 | SELL | 5,017 | $8.75 | $43.9K |
| GRAMMER ELIZABETH A | See Remarks | 2024-02-20 | SELL | 4,432 | $8.75 | $38.8K |
| Rodriguez Susan | Chief Commercial Officer | 2024-02-20 | SELL | 6,928 | $8.75 | $60.6K |
| Felsch Robert Ora | See Remarks | 2024-02-20 | SELL | 2,352 | $8.75 | $20.6K |
| Williams Laura A | Chief Medical Officer | 2024-02-20 | SELL | 4,803 | $8.75 | $42K |
| Rosenbaum David P. | Chief Development Officer | 2024-02-08 | SELL | 15,344 | $9.18 | $140.9K |
| Rosenbaum David P. | Chief Development Officer | 2024-01-08 | SELL | 30,000 | $6.64 | $199.2K |
| Renz Justin A | CFO | 2023-12-26 | SELL | 225,000 | $6.36 | $1431K |
| Rosenbaum David P. | Chief Development Officer | 2023-12-18 | SELL | 5,675 | $6.07 | $34.4K |
| Rosenbaum David P. | Chief Development Officer | 2023-12-14 | SELL | 7,000 | $5.55 | $38.9K |
| GRAMMER ELIZABETH A | See Remarks | 2023-12-11 | SELL | 50,000 | $5.08 | $254K |
| Rosenbaum David P. | Chief Development Officer | 2023-12-08 | SELL | 20,000 | $5.27 | $105.4K |
| Rosenbaum David P. | Chief Development Officer | 2023-12-05 | SELL | 10,272 | $5 | $51.4K |
| Rosenbaum David P. | Chief Development Officer | 2023-11-30 | SELL | 3,000 | $4.5 | $13.5K |
| GRAMMER ELIZABETH A | See Remarks | 2023-11-20 | SELL | 2,384 | $4.36 | $10.4K |
| Felsch Robert Ora | See Remarks | 2023-11-20 | SELL | 1,044 | $4.36 | $4.6K |
| Blanks Robert | See Remarks | 2023-11-20 | SELL | 2,835 | $4.36 | $12.4K |
| Williams Laura A | Chief Medical Officer | 2023-11-20 | SELL | 2,581 | $4.36 | $11.3K |
| Rosenbaum David P. | Chief Development Officer | 2023-11-20 | SELL | 3,767 | $4.36 | $16.4K |
| Rodriguez Susan | Chief Commercial Officer | 2023-11-20 | SELL | 4,714 | $4.36 | $20.6K |
| Renz Justin A | CFO | 2023-11-20 | SELL | 2,873 | $4.36 | $12.5K |
| RAAB MICHAEL | President & CEO | 2023-11-20 | SELL | 11,368 | $4.36 | $49.6K |
| Williams Laura A | Chief Medical Officer | 2023-11-15 | SELL | 25,000 | $4 | $100K |
| Rosenbaum David P. | Chief Development Officer | 2023-10-10 | SELL | 1,644 | $4 | $6.6K |
| Rosenbaum David P. | Chief Development Officer | 2023-09-08 | SELL | 2,897 | $4.55 | $13.2K |
| Rodriguez Susan | Chief Commercial Officer | 2023-08-21 | SELL | 4,733 | $3.55 | $16.8K |
| Williams Laura A | Chief Medical Officer | 2023-08-21 | SELL | 2,591 | $3.55 | $9.2K |
| Rosenbaum David P. | Chief Development Officer | 2023-08-21 | SELL | 3,783 | $3.55 | $13.4K |
| Renz Justin A | CFO | 2023-08-21 | SELL | 2,884 | $3.55 | $10.2K |
| RAAB MICHAEL | President & CEO | 2023-08-21 | SELL | 11,419 | $3.55 | $40.5K |
| GRAMMER ELIZABETH A | See Remarks | 2023-08-21 | SELL | 2,392 | $3.55 | $8.5K |
| Felsch Robert Ora | See Remarks | 2023-08-21 | SELL | 1,048 | $3.55 | $3.7K |
| Blanks Robert | See Remarks | 2023-08-21 | SELL | 2,846 | $3.55 | $10.1K |
| Williams Laura A | Chief Medical Officer | 2023-06-27 | SELL | 25,000 | $3.35 | $83.8K |
| Blanks Robert | See Remarks | 2023-06-23 | SELL | 33,333 | $3.63 | $121K |
| Felsch Robert Ora | See Remarks | 2023-05-23 | SELL | 1,046 | $3.65 | $3.8K |
| RAAB MICHAEL | President & CEO | 2023-05-23 | SELL | 11,357 | $3.65 | $41.5K |
| GRAMMER ELIZABETH A | See Remarks | 2023-05-23 | SELL | 2,384 | $3.65 | $8.7K |
| Blanks Robert | See Remarks | 2023-05-23 | SELL | 2,835 | $3.65 | $10.3K |
| Renz Justin A | CFO | 2023-05-23 | SELL | 2,873 | $3.65 | $10.5K |
| Rodriguez Susan | Chief Commercial Officer | 2023-05-23 | SELL | 4,711 | $3.65 | $17.2K |
| Rosenbaum David P. | Chief Development Officer | 2023-05-23 | SELL | 3,769 | $3.65 | $13.8K |
| Williams Laura A | Chief Medical Officer | 2023-05-23 | SELL | 2,583 | $3.65 | $9.4K |
| Rosenbaum David P. | Chief Development Officer | 2023-03-29 | SELL | 3,000 | $4.63 | $13.9K |
| Williams Laura A | Chief Medical Officer | 2023-02-21 | SELL | 3,187 | $3 | $9.6K |
| Blanks Robert | See Remarks | 2023-02-21 | SELL | 3,394 | $3 | $10.2K |
| GRAMMER ELIZABETH A | See Remarks | 2023-02-21 | SELL | 2,914 | $3 | $8.7K |
| RAAB MICHAEL | President & CEO | 2023-02-21 | SELL | 13,449 | $3 | $40.3K |
| Felsch Robert Ora | See Remarks | 2023-02-21 | SELL | 3,214 | $3 | $9.6K |
| Renz Justin A | CFO | 2023-02-21 | SELL | 3,439 | $3 | $10.3K |
| Rosenbaum David P. | Chief Development Officer | 2023-02-21 | SELL | 4,508 | $3 | $13.5K |
| Rosenbaum David P. | Chief Development Officer | 2022-11-22 | SELL | 1,948 | $1.95 | $3.8K |
| GRAMMER ELIZABETH A | See Remarks | 2022-11-22 | SELL | 1,242 | $1.95 | $2.4K |
| Rodriguez Susan | Chief Commercial Officer | 2022-11-22 | SELL | 3,456 | $1.95 | $6.7K |
| RAAB MICHAEL | President & CEO | 2022-11-22 | SELL | 6,219 | $1.95 | $12.1K |
| Renz Justin A | CFO | 2022-11-22 | SELL | 1,504 | $1.95 | $2.9K |
| Williams Laura A | Chief Medical Officer | 2022-11-22 | SELL | 1,241 | $1.95 | $2.4K |
| Blanks Robert | See Remarks | 2022-11-22 | SELL | 1,464 | $1.95 | $2.9K |
| MOTT DAVID M | Director | 2022-11-17 | BUY | 567,000 | $1.76 | $997.9K |
| Blanks Robert | See Remarks | 2022-10-05 | SELL | 100,000 | $1.5 | $150K |
| Rosenbaum David P. | Chief Development Officer | 2022-09-01 | SELL | 3,000 | $0.92 | $2.8K |
| Felsch Robert Ora | See Remarks | 2022-08-31 | BUY | 3,000 | $0.62 | $1.9K |
| Rosenbaum David P. | Chief Development Officer | 2022-08-31 | BUY | 3,000 | $0.62 | $1.9K |
| Renz Justin A | CFO | 2022-08-31 | BUY | 3,000 | $0.62 | $1.9K |
| Williams Laura A | Chief Medical Officer | 2022-08-31 | BUY | 3,000 | $0.62 | $1.9K |
| RAAB MICHAEL | President & CEO | 2022-08-31 | BUY | 3,000 | $0.62 | $1.9K |
| GRAMMER ELIZABETH A | See Remarks | 2022-08-31 | BUY | 3,000 | $0.62 | $1.9K |
| Blanks Robert | See Remarks | 2022-08-26 | SELL | 21,842 | $1.04 | $22.7K |
| Rodriguez Susan | Chief Commercial Officer | 2022-08-22 | SELL | 3,420 | $0.98 | $3.4K |
| Rosenbaum David P. | Chief Development Officer | 2022-08-22 | SELL | 1,955 | $0.98 | $1.9K |
| Blanks Robert | See Remarks | 2022-08-22 | SELL | 1,458 | $0.98 | $1.4K |
| RAAB MICHAEL | President & CEO | 2022-08-22 | SELL | 6,146 | $0.98 | $6K |
| GRAMMER ELIZABETH A | See Remarks | 2022-08-22 | SELL | 1,236 | $0.98 | $1.2K |
| Williams Laura A | Chief Medical Officer | 2022-08-22 | SELL | 1,276 | $0.98 | $1.3K |
| Renz Justin A | CFO | 2022-08-22 | SELL | 1,498 | $0.98 | $1.5K |
| Blanks Robert | See Remarks | 2022-07-26 | SELL | 5,188 | $0.67 | $3.5K |
| Renz Justin A | CFO | 2022-06-06 | SELL | 73,312 | $0.65 | $47.7K |
| Rodriguez Susan | Chief Commercial Officer | 2022-06-06 | SELL | 43,920 | $0.65 | $28.5K |
| Blanks Robert | See Remarks | 2022-06-06 | SELL | 73,312 | $0.65 | $47.7K |
| GRAMMER ELIZABETH A | See Remarks | 2022-06-06 | SELL | 60,821 | $0.65 | $39.5K |
| Rosenbaum David P. | Chief Development Officer | 2022-06-06 | SELL | 61,640 | $0.65 | $40.1K |
| RAAB MICHAEL | President & CEO | 2022-06-06 | SELL | 103,624 | $0.65 | $67.4K |
| Rosenbaum David P. | Chief Development Officer | 2022-05-20 | SELL | 2,013 | $0.67 | $1.3K |
| Renz Justin A | CFO | 2022-05-20 | SELL | 1,528 | $0.67 | $1K |
| Rodriguez Susan | Chief Commercial Officer | 2022-05-20 | SELL | 3,425 | $0.67 | $2.3K |
| Blanks Robert | See Remarks | 2022-05-20 | SELL | 1,489 | $0.67 | $1K |
| RAAB MICHAEL | President & CEO | 2022-05-20 | SELL | 6,124 | $0.67 | $4.1K |
| GRAMMER ELIZABETH A | See Remarks | 2022-05-20 | SELL | 1,263 | $0.67 | $0.8K |
| Renz Justin A | CFO | 2022-02-22 | SELL | 1,800 | $0.67 | $1.2K |
| Blanks Robert | See Remarks | 2022-02-22 | SELL | 1,752 | $0.67 | $1.2K |
| RAAB MICHAEL | President & CEO | 2022-02-22 | SELL | 6,229 | $0.67 | $4.2K |
| GRAMMER ELIZABETH A | See Remarks | 2022-02-22 | SELL | 1,528 | $0.67 | $1K |
| Rosenbaum David P. | Chief Development Officer | 2022-02-22 | SELL | 2,353 | $0.67 | $1.6K |
| Rodriguez Susan | Chief Commercial Officer | 2022-02-22 | SELL | 3,400 | $0.67 | $2.3K |
| SANDELL SCOTT D | 10% Owner | 2021-12-15 | SELL | 2,881,570 | $1.26 | $3630.8K |
| BASKETT FOREST | 10% Owner | 2021-12-15 | SELL | 2,881,570 | $1.26 | $3630.8K |
| Blanks Robert | See Remarks | 2021-11-22 | SELL | 643 | $0.99 | $0.6K |
| GRAMMER ELIZABETH A | See Remarks | 2021-11-22 | SELL | 537 | $0.99 | $0.5K |
| Rosenbaum David P. | Chief Development Officer | 2021-11-22 | SELL | 827 | $0.99 | $0.8K |
| Rodriguez Susan | Chief Commercial Officer | 2021-11-22 | SELL | 643 | $0.99 | $0.6K |
| Renz Justin A | CFO | 2021-11-22 | SELL | 643 | $0.99 | $0.6K |
| RAAB MICHAEL | President & CEO | 2021-11-22 | SELL | 2,607 | $0.99 | $2.6K |
| Jacobs Jeffrey W | Chief Scientific Officer | 2021-11-22 | SELL | 5,754 | $0.98 | $5.6K |
| Jacobs Jeffrey W | Chief Scientific Officer | 2021-11-15 | SELL | 5,000 | $1.13 | $5.7K |
| GRAMMER ELIZABETH A | See Remarks | 2021-11-12 | SELL | 77,432 | $1.13 | $87.5K |
| Jacobs Jeffrey W | Chief Scientific Officer | 2021-11-08 | SELL | 2,166 | $1.18 | $2.6K |
| Rosenbaum David P. | Chief Development Officer | 2021-08-20 | SELL | 807 | $1.32 | $1.1K |
| Rodriguez Susan | Chief Commercial Officer | 2021-08-20 | SELL | 630 | $1.32 | $0.8K |
| Renz Justin A | CFO | 2021-08-20 | SELL | 631 | $1.32 | $0.8K |
| RAAB MICHAEL | President & CEO | 2021-08-20 | SELL | 2,573 | $1.32 | $3.4K |
| Jacobs Jeffrey W | Chief Scientific Officer | 2021-08-20 | SELL | 741 | $1.32 | $1K |
| GRAMMER ELIZABETH A | See Remarks | 2021-08-20 | SELL | 526 | $1.32 | $0.7K |
| Blanks Robert | See Remarks | 2021-08-20 | SELL | 631 | $1.32 | $0.8K |
| Jacobs Jeffrey W | Chief Scientific Officer | 2021-06-15 | SELL | 7,500 | $7.29 | $54.7K |
| Rosenbaum David P. | Chief Development Officer | 2021-05-20 | SELL | 769 | $7.09 | $5.5K |
| Rodriguez Susan | Chief Commercial Officer | 2021-05-20 | SELL | 611 | $7.09 | $4.3K |
| Renz Justin A | CFO | 2021-05-20 | SELL | 612 | $7.09 | $4.3K |
| RAAB MICHAEL | President & CEO | 2021-05-20 | SELL | 2,534 | $7.09 | $18K |
| Jacobs Jeffrey W | Chief Scientific Officer | 2021-05-20 | SELL | 721 | $7.09 | $5.1K |
| GRAMMER ELIZABETH A | See Remarks | 2021-05-20 | SELL | 508 | $7.09 | $3.6K |
| Blanks Robert | See Remarks | 2021-05-20 | SELL | 612 | $7.09 | $4.3K |
| Rosenbaum David P. | Chief Development Officer | 2021-04-06 | SELL | 5,000 | $8 | $40K |
| Blanks Robert | See Remarks | 2021-04-06 | SELL | 5,163 | $8 | $41.3K |
| Blanks Robert | See Remarks | 2021-02-22 | SELL | 593 | $6.88 | $4.1K |
| Jacobs Jeffrey W | Chief Scientific Officer | 2021-02-22 | SELL | 702 | $6.88 | $4.8K |
| Rodriguez Susan | Chief Commercial Officer | 2021-02-22 | SELL | 611 | $6.88 | $4.2K |
| RAAB MICHAEL | President & CEO | 2021-02-22 | SELL | 2,534 | $6.88 | $17.4K |
| Rosenbaum David P. | Chief Development Officer | 2021-02-22 | SELL | 805 | $6.88 | $5.5K |
| Renz Justin A | CFO | 2021-02-22 | SELL | 608 | $6.88 | $4.2K |
| GRAMMER ELIZABETH A | See Remarks | 2021-02-22 | SELL | 504 | $6.88 | $3.5K |
| Jacobs Jeffrey W | Chief Scientific Officer | 2020-12-21 | SELL | 3,949 | $6.88 | $27.2K |
| GRAMMER ELIZABETH A | See Remarks | 2020-12-14 | SELL | 42,000 | $7.3 | $306.6K |
| MOTT DAVID M | Director | 2020-12-10 | BUY | 170,000 | $5.89 | $1001.3K |
| Rodriguez Susan | Chief Commercial Officer | 2020-09-16 | SELL | 6,087 | $6.11 | $37.2K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2020-09-16 | SELL | 50,804 | $5.63 | $286K |
| Rosenbaum David P. | Chief Development Officer | 2020-09-15 | SELL | 38,126 | $5.52 | $210.5K |
| Blanks Robert | See Remarks | 2020-09-15 | SELL | 34,685 | $5.45 | $189K |
| Renz Justin A | CFO | 2020-09-15 | SELL | 3,714 | $5.49 | $20.4K |
| RAAB MICHAEL | President & CEO | 2020-09-15 | SELL | 106,337 | $5.61 | $596.6K |
| GRAMMER ELIZABETH A | See Remarks | 2020-09-15 | SELL | 28,810 | $5.37 | $154.7K |
| Blanks Robert | See Remarks | 2020-09-01 | SELL | 2,049 | $5.58 | $11.4K |
| RAAB MICHAEL | President & CEO | 2020-07-02 | SELL | 23,128 | $7.01 | $162.1K |
| MOTT DAVID M | Director | 2020-06-25 | BUY | 140,971 | $6.85 | $965.7K |
| MOTT DAVID M | Director | 2020-06-22 | BUY | 4,673 | $6.75 | $31.5K |
| SANDELL SCOTT D | 10% Owner | 2020-06-15 | SELL | 43 | $6.37 | $0.3K |
| BASKETT FOREST | 10% Owner | 2020-06-15 | SELL | 43 | $6.37 | $0.3K |
| SANDELL SCOTT D | 10% Owner | 2020-06-12 | SELL | 89,983 | $6.37 | $573.2K |
| BASKETT FOREST | 10% Owner | 2020-06-12 | SELL | 112,883 | $6.37 | $719.1K |
| RAAB MICHAEL | President & CEO | 2020-06-01 | SELL | 23,128 | $7.33 | $169.5K |
| RAAB MICHAEL | President & CEO | 2020-05-05 | SELL | 20,427 | $7.01 | $143.2K |
| GRAMMER ELIZABETH A | See Remarks | 2020-04-27 | SELL | 17,824 | $7.47 | $133.1K |
| RAAB MICHAEL | President & CEO | 2020-04-17 | SELL | 20,428 | $7.02 | $143.4K |
| RAAB MICHAEL | President & CEO | 2020-03-02 | SELL | 31,551 | $7.01 | $221.2K |
| RAAB MICHAEL | President & CEO | 2020-02-05 | SELL | 25,000 | $7.32 | $183K |
| GRAMMER ELIZABETH A | EVP, General Counsel | 2019-12-30 | BUY | 66 | $7.51 | $0.5K |
| GRAMMER ELIZABETH A | EVP, General Counsel | 2019-12-03 | SELL | 5,000 | $8 | $40K |
| GRAMMER ELIZABETH A | EVP, General Counsel | 2019-11-19 | SELL | 5,000 | $7 | $35K |
| Kaufmann Mark | CFO | 2019-10-07 | SELL | 20,000 | $4.56 | $91.2K |
| GRAMMER ELIZABETH A | EVP, General Counsel | 2019-08-22 | SELL | 5,000 | $3.5 | $17.5K |
| GRAMMER ELIZABETH A | EVP, General Counsel | 2019-08-19 | SELL | 5,874 | $3 | $17.6K |
| Rosenbaum David P. | Chief Development Officer | 2019-06-04 | SELL | 2,856 | $2.54 | $7.3K |
| RAAB MICHAEL | President & CEO | 2019-06-04 | SELL | 10,054 | $2.54 | $25.5K |
| Kaufmann Mark | CFO | 2019-06-04 | SELL | 3,357 | $2.55 | $8.6K |
| GRAMMER ELIZABETH A | SVP, General Counsel | 2019-06-04 | SELL | 2,520 | $2.54 | $6.4K |
| Rosenbaum David P. | Chief Development Officer | 2019-01-02 | SELL | 6,386 | $1.7 | $10.9K |
| RAAB MICHAEL | President & CEO | 2019-01-02 | SELL | 19,644 | $1.7 | $33.4K |
| Kaufmann Mark | CFO | 2019-01-02 | SELL | 6,556 | $1.7 | $11.1K |
| GRAMMER ELIZABETH A | EVP, General Counsel | 2019-01-02 | SELL | 4,920 | $1.7 | $8.4K |
| RAAB MICHAEL | President & CEO | 2018-11-13 | SELL | 6,539 | $2.84 | $18.6K |
| Kaufmann Mark | CFO | 2018-11-13 | SELL | 6,539 | $2.84 | $18.6K |
| Rosenbaum David P. | Chief Development Officer | 2018-11-13 | SELL | 5,570 | $2.84 | $15.8K |
| GRAMMER ELIZABETH A | EVP, General Counsel | 2018-11-13 | SELL | 6,539 | $2.84 | $18.6K |
| SANDELL SCOTT D | 10% Owner | 2018-11-12 | SELL | 592 | $2.98 | $1.8K |
| RINGOLD GORDON | Director | 2018-05-30 | BUY | 10,000 | $4 | $40K |
| Seeto Reginald | COO | 2017-10-24 | SELL | 10,008 | $5.2 | $52K |
| BASKETT FOREST | 10% Owner | 2017-08-30 | SELL | 485 | $4.95 | $2.4K |
| Rosenbaum David P. | Chief Development Officer | 2017-04-18 | SELL | 2,051 | $11.98 | $24.6K |
| Rosenbaum David P. | SVP, Drug Development | 2017-03-10 | SELL | 1,000 | $13.48 | $13.5K |
| Caldwell Jeremy S | EVP, Chief Scientific Officer | 2017-03-03 | SELL | 1,026 | $14.14 | $14.5K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2017-03-01 | SELL | 3,000 | $13.7 | $41.1K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2017-02-01 | SELL | 3,000 | $12 | $36K |
| Korner Paul | EVP, Chief Medical Officer | 2017-01-05 | SELL | 6,130 | $12.95 | $79.4K |
| Rosenbaum David P. | SVP, Drug Development | 2016-12-16 | SELL | 900 | $14.48 | $13K |
| Caldwell Jeremy S | EVP, Chief Scientific Officer | 2016-11-11 | SELL | 2,158 | $15.13 | $32.7K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2016-10-11 | SELL | 6,000 | $15 | $90K |
| GRAMMER ELIZABETH A | SVP, General Counsel | 2016-09-23 | SELL | 5,000 | $12 | $60K |
| GRAMMER ELIZABETH A | SVP, General Counsel | 2016-09-19 | SELL | 6,859 | $11.21 | $76.9K |
| Weller Harry R | 10% Owner | 2016-07-18 | BUY | 1,527,301 | $8.73 | $13333.3K |
| Viswanathan Ravi | 10% Owner | 2016-07-18 | BUY | 1,527,301 | $8.73 | $13333.3K |
| Sonsini Peter W. | 10% Owner | 2016-07-18 | BUY | 1,527,301 | $8.73 | $13333.3K |
| SANDELL SCOTT D | 10% Owner | 2016-07-18 | BUY | 2,290,951 | $8.73 | $20000K |
| Sakoda Jon | 10% Owner | 2016-07-18 | BUY | 1,527,301 | $8.73 | $13333.3K |
| MOTT DAVID M | Director, 10% Owner | 2016-07-18 | BUY | 1,527,301 | $8.73 | $13333.3K |
| MAKOWER JOSHUA | 10% Owner | 2016-07-18 | BUY | 1,527,301 | $8.73 | $13333.3K |
| KOLLURI KRISHNA KITTU | 10% Owner | 2016-07-18 | BUY | 2,290,951 | $8.73 | $20000K |
| KERINS PATRICK J | 10% Owner | 2016-07-18 | BUY | 763,650 | $8.73 | $6666.7K |
| Florence Anthony A. Jr. | 10% Owner | 2016-07-18 | BUY | 1,527,301 | $8.73 | $13333.3K |
| BASKETT FOREST | 10% Owner | 2016-07-18 | BUY | 2,290,951 | $8.73 | $20000K |
| BARRIS PETER J | 10% Owner | 2016-07-18 | BUY | 2,290,951 | $8.73 | $20000K |
| BARRETT M JAMES | 10% Owner | 2016-07-18 | BUY | 763,650 | $8.73 | $6666.7K |
| New Enterprise Associates 12, | 10% Owner | 2016-07-18 | BUY | 763,650 | $8.73 | $6666.7K |
| NEA 15 GP, LLC | 10% Owner | 2016-07-18 | BUY | 1,527,301 | $8.73 | $13333.3K |
| RINGOLD GORDON | Director | 2016-03-21 | BUY | 15,000 | $7.77 | $116.6K |
| Rosenbaum David P. | SVP, Drug Development | 2016-03-03 | SELL | 1,128 | $10.74 | $12.1K |
| Kaufmann Mark | CFO | 2016-02-16 | SELL | 5,000 | $10.25 | $51.3K |
| Sakoda Jon | 10% Owner | 2016-01-13 | BUY | 1,000,000 | $10 | $10000K |
| Weller Harry R | 10% Owner | 2016-01-13 | BUY | 1,000,000 | $10 | $10000K |
| Viswanathan Ravi | 10% Owner | 2016-01-13 | BUY | 1,000,000 | $10 | $10000K |
| Sonsini Peter W. | 10% Owner | 2016-01-13 | BUY | 1,000,000 | $10 | $10000K |
| SANDELL SCOTT D | 10% Owner | 2016-01-13 | BUY | 1,500,000 | $10 | $15000K |
| MOTT DAVID M | Director, 10% Owner | 2016-01-13 | BUY | 1,000,000 | $10 | $10000K |
| MAKOWER JOSHUA | 10% Owner | 2016-01-13 | BUY | 1,000,000 | $10 | $10000K |
| KOLLURI KRISHNA KITTU | 10% Owner | 2016-01-13 | BUY | 1,500,000 | $10 | $15000K |
| KERINS PATRICK J | 10% Owner | 2016-01-13 | BUY | 500,000 | $10 | $5000K |
| Florence Anthony A. Jr. | 10% Owner | 2016-01-13 | BUY | 1,000,000 | $10 | $10000K |
| BASKETT FOREST | 10% Owner | 2016-01-13 | BUY | 1,500,000 | $10 | $15000K |
| BARRIS PETER J | 10% Owner | 2016-01-13 | BUY | 1,500,000 | $10 | $15000K |
| BARRETT M JAMES | 10% Owner | 2016-01-13 | BUY | 500,000 | $10 | $5000K |
| New Enterprise Associates 12, | 10% Owner | 2016-01-13 | BUY | 500,000 | $10 | $5000K |
| NEA 15 GP, LLC | 10% Owner | 2016-01-13 | BUY | 1,000,000 | $10 | $10000K |
| Bertrand William C JR | Director | 2015-12-17 | BUY | 5,000 | $20 | $100K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2015-12-15 | SELL | 2,000 | $20 | $40K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2015-11-27 | SELL | 2,000 | $20 | $40K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2015-10-08 | SELL | 2,000 | $19.88 | $39.8K |
| Rosenbaum David P. | SVP, Drug Development | 2015-09-22 | SELL | 1,400 | $22.05 | $30.9K |
| Rosenbaum David P. | SVP, Drug Development | 2015-09-22 | SELL | 1,400 | $22.05 | $30.9K |
| Rosenbaum David P. | SVP, Drug Development | 2015-09-15 | SELL | 2,540 | $22.01 | $55.9K |
| Rosenbaum David P. | SVP, Drug Development | 2015-09-15 | SELL | 2,540 | $22.01 | $55.9K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2015-09-10 | SELL | 2,000 | $20.59 | $41.2K |
| RAAB MICHAEL | President & CEO | 2015-09-08 | SELL | 9,785 | $20.29 | $198.5K |
| Rosenbaum David P. | SVP, Drug Development | 2015-09-03 | SELL | 2,537 | $18.78 | $47.6K |
| Caldwell Jeremy S | EVP, Chief Scientific Officer | 2015-09-01 | SELL | 643 | $18.32 | $11.8K |
| GRAMMER ELIZABETH A | VP, General Counsel | 2015-09-01 | SELL | 893 | $18.32 | $16.4K |
| RAAB MICHAEL | President & CEO | 2015-08-18 | SELL | 1,104 | $20 | $22.1K |
| Jacobs Jeffrey W | SVP, Technical Operations | 2015-08-06 | SELL | 2,000 | $19.07 | $38.1K |
| RAAB MICHAEL | President & CEO | 2015-08-03 | SELL | 300 | $20 | $6K |
| Rosenbaum David P. | SVP, Drug Development | 2015-07-30 | SELL | 2,011 | $19.27 | $38.8K |
| Rosenbaum David P. | SVP, Drug Development | 2015-07-30 | SELL | 2,011 | $19.27 | $38.8K |
| Jacobs Jeffrey W | Senior VP, Technical Ops | 2015-07-28 | SELL | 2,500 | $20 | $50K |
| RAAB MICHAEL | President & CEO | 2015-07-28 | SELL | 2,111 | $20 | $42.2K |
| GRAMMER ELIZABETH A | VP, General Counsel | 2015-07-22 | SELL | 2,500 | $18 | $45K |
| GRAMMER ELIZABETH A | VP, General Counsel | 2015-07-15 | SELL | 10,000 | $17.12 | $171.2K |
| RINGOLD GORDON | Director | 2015-06-10 | BUY | 10,000 | $15.19 | $151.9K |
| SCHULTZ PETER G | Director | 2015-06-05 | BUY | 46,729 | $10.7 | $500K |
| BARRIS PETER J | 10% Owner | 2015-06-05 | BUY | 4,672,897 | $10.7 | $50000K |
| BARRETT M JAMES | 10% Owner | 2015-06-05 | BUY | 1,869,159 | $10.7 | $20000K |
| BASKETT FOREST | 10% Owner | 2015-06-05 | BUY | 4,672,897 | $10.7 | $50000K |
| DRANT RYAN D | 10% Owner | 2015-06-05 | BUY | 1,869,159 | $10.7 | $20000K |
| KERINS PATRICK J | 10% Owner | 2015-06-05 | BUY | 1,869,159 | $10.7 | $20000K |
| SANDELL SCOTT D | 10% Owner | 2015-06-05 | BUY | 4,672,897 | $10.7 | $50000K |
| KOLLURI KRISHNA KITTU | 10% Owner | 2015-06-05 | BUY | 4,672,897 | $10.7 | $50000K |
| MOTT DAVID M | Director, 10% Owner | 2015-06-05 | BUY | 2,803,738 | $10.7 | $30000K |
| New Enterprise Associates 12, | 10% Owner | 2015-06-05 | BUY | 1,869,159 | $10.7 | $20000K |
| Kaufmann Mark | CFO | 2015-05-04 | SELL | 9,083 | $10.81 | $98.2K |
| Kaufmann Mark | CFO | 2015-04-06 | SELL | 7,681 | $12.8 | $98.3K |
| Kaufmann Mark | CFO | 2015-03-03 | SELL | 6,075 | $15.6 | $94.8K |
| JUE GEORGE | VP, Operations | 2015-03-02 | SELL | 1,500 | $15.88 | $23.8K |
| GRAMMER ELIZABETH A | VP, General Counsel | 2015-03-02 | SELL | 1,737 | $15.81 | $27.5K |
| Jacobs Jeffrey W | VP, Chemistry | 2015-03-02 | SELL | 981 | $15.81 | $15.5K |
| Jacobs Jeffrey W | VP, Chemistry | 2015-02-04 | SELL | 8,888 | $16.28 | $144.7K |
| CMEA Ventures VII LP | 10% Owner | 2015-01-30 | SELL | 170,000 | $27.37 | $4652.9K |
| CMEA Ventures VII LP | 10% Owner | 2015-01-08 | SELL | 300,000 | $24.25 | $7275K |
| KOLLURI KRISHNA KITTU | 10% Owner | 2014-12-29 | SELL | 267 | $20.09 | $5.4K |
| BARRIS PETER J | 10% Owner | 2014-12-26 | SELL | 1,972 | $21.28 | $42K |
| BARRETT M JAMES | 10% Owner | 2014-12-26 | SELL | 2,564 | $21.34 | $54.7K |
| BASKETT FOREST | 10% Owner | 2014-12-26 | SELL | 1,972 | $21.28 | $42K |
| SANDELL SCOTT D | 10% Owner | 2014-12-26 | SELL | 1,972 | $21.28 | $42K |
| CMEA Ventures VII LP | 10% Owner | 2014-06-24 | BUY | 316,826 | $14 | $4435.6K |
| New Enterprise Associates 12, | 10% Owner | 2014-06-24 | BUY | 510,442 | $14 | $7146.2K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked